Back
NovoCure Vs. Nike Industry Stock Comparison
Sell
18
NVCR
NovoCure
Last Price:
17.02
Seasonality Move:
7.1%
Sell
17
NKE
Nike
Last Price:
75.21
Seasonality Move:
6.25%
Sell
18
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $16.80. The Score for NVCR is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $76.04. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
NKE Stock Price Chart
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.78 | Sell |
Relative Strength Index (14 RSI): | 31.96 | Sell |
Chaikin Money Flow: | -699765 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.33 - 22.47) | Sell |
Bollinger Bands (100): | (13.29 - 20.19) | Buy |
NKE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.2 | Sell |
Relative Strength Index (14 RSI): | 21.68 | Sell |
Chaikin Money Flow: | -4026097 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.28 - 98.68) | Sell |
Bollinger Bands (100): | (89.69 - 101.25) | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.86 | Sell |
20-day SMA: | 19.87 | Sell |
50-day SMA: | 18.74 | Sell |
200-day SMA: | 15.38 | Buy |
8-day EMA: | 17.88 | Sell |
20-day EMA: | 19.08 | Sell |
50-day EMA: | 18.71 | Sell |
200-day EMA: | 21.52 | Sell |
NKE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.2 | Sell |
20-day SMA: | 92.27 | Sell |
50-day SMA: | 92.61 | Sell |
200-day SMA: | 100.01 | Sell |
8-day EMA: | 85 | Sell |
20-day EMA: | 89.87 | Sell |
50-day EMA: | 92.49 | Sell |
200-day EMA: | 99.26 | Sell |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.01 per share, an increase this year of $0.42 per share, and a decrease next year of $0.10 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.
NovoCure Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nike Technical Analysis
Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |